1 – 50 of 106
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort
2024) In Journal of Neurology(
- Contribution to journal › Article
-
Mark
Investigating reliable amyloid accumulation in Centiloids : Results from the AMYPAD Prognostic and Natural History Study
2024) In Alzheimer's and Dementia(
- Contribution to journal › Article
- 2023
-
Mark
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance
(
- Contribution to journal › Article
-
Mark
Clinical performance and robustness evaluation of plasma amyloid-β42/40 prescreening
(
- Contribution to journal › Article
-
Mark
Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors
(
- Contribution to journal › Article
-
Mark
Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies
(
- Contribution to journal › Article
-
Mark
How Do Modifiable Risk Factors Affect Alzheimer's Disease Pathology or Mitigate Its Effect on Clinical Symptom Expression?
2023) In Biological Psychiatry(
- Contribution to journal › Scientific review
-
Mark
Impact of simulated reduced injected dose on the assessment of amyloid PET scans
2023) In European Journal of Nuclear Medicine and Molecular Imaging(
- Contribution to journal › Article
-
Mark
Longitudinal amyloid and tau PET imaging in Alzheimer's disease : A systematic review of methodologies and factors affecting quantification
(
- Contribution to journal › Scientific review
-
Mark
Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease
(
- Contribution to journal › Article
- 2022
-
Mark
Characteristics of subjective cognitive decline associated with amyloid positivity
(
- Contribution to journal › Article
-
Mark
The BIN1 rs744373 Alzheimer's disease risk SNP is associated with faster Aβ-associated tau accumulation and cognitive decline
(
- Contribution to journal › Article
-
Mark
Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau
(
- Contribution to journal › Article
-
Mark
Medial Temporal Lobe Networks in Alzheimer's Disease : Structural and Molecular Vulnerabilities
2022) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 42(10). p.2131-2141(
- Contribution to journal › Article
-
Mark
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
(
- Contribution to journal › Article
-
Mark
Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults : Effects of Alzheimer's Disease Pathology and Cognitive Decline
(
- Contribution to journal › Article
-
Mark
Neuropsychiatric symptoms in early stages of Alzheimer’s disease: associations with neuropathological changes and cognitive deficits
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Role of Hydrophobicity at the N-Terminal Region of Aβ42 in Secondary Nucleation
(
- Contribution to journal › Article
-
Mark
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
(
- Contribution to journal › Article
-
Mark
Alzheimer Disease : Standard of Diagnosis, Treatment, Care, and Prevention
(
- Contribution to journal › Article
-
Mark
The future of clinical trials for Alzheimer's disease. A blood-based biomarker perspective
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Quantification of amyloid PET for future clinical use : a state-of-the-art review
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
(
- Contribution to journal › Article
-
Mark
Astrocytic and Neuronal Apolipoprotein E Isoforms Differentially Affect Neuronal Excitability
(
- Contribution to journal › Article
-
Mark
Co-assembly of proteins and lipids : From lipodiscs to amyloid aggregates
2021)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The impact of amyloid burden and APOE on rates of cognitive impairment in late life depression
(
- Contribution to journal › Article
-
Mark
pH-Responsive Capsules with a Fibril Scaffold Shell Assembled from an Amyloidogenic Peptide
(
- Contribution to journal › Article
-
Mark
Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging
(
- Contribution to journal › Article
-
Mark
Neuronal spreading and plaque induction of intracellular Aβ and its disruption of Aβ homeostasis
(
- Contribution to journal › Article
-
Mark
Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau
(
- Contribution to journal › Article
-
Mark
Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden : Findings From the Alzheimer's Disease Neuroimaging Initiative Depression Project
(
- Contribution to journal › Article
-
Mark
Polyoxometalates as Effective Nano-inhibitors of Amyloid Aggregation of Pro-inflammatory S100A9 Protein Involved in Neurodegenerative Diseases
(
- Contribution to journal › Article
- 2020
-
Mark
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course - A joint PhD student course at University College London and University of Gothenburg
(
- Contribution to journal › Scientific review
-
Mark
The properties of α-synuclein secondary nuclei are dominated by the solution conditions rather than the seed fibril strain
(
- Contribution to journal › Article
-
Mark
Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults
2020) In European Journal of Nuclear Medicine and Molecular Imaging(
- Contribution to journal › Article
-
Mark
Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
(
- Contribution to journal › Article
-
Mark
Amyloid-specific extraction using organic solvents
(
- Contribution to journal › Article
-
Mark
Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(39). p.24251-24257(
- Contribution to journal › Article
-
Mark
The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(41). p.25272-25283(
- Contribution to journal › Article
-
Mark
Secondary Nucleation in Amyloid Formation
2020)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Relevance of biomarkers across different neurodegenerative
(
- Contribution to journal › Scientific review
-
Mark
Kinetic diversity of amyloid oligomers
(
- Contribution to journal › Article
-
Mark
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein
(
- Contribution to journal › Article
- 2019
-
Mark
APP depletion alters selective pre- and post-synaptic proteins
(
- Contribution to journal › Article
-
Mark
Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort : The ABIDE project
2019) In Alzheimer's and Dementia(
- Contribution to journal › Article
-
Mark
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
(
- Contribution to journal › Article
-
Mark
A new perspective for advanced positron emission tomography–based molecular imaging in neurodegenerative proteinopathies
(
- Contribution to journal › Article
-
Mark
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
(
- Contribution to journal › Article
- 2018
-
Mark
Abnormal structural brain connectome in individuals with preclinical Alzheimer's disease
(
- Contribution to journal › Article